ReviewEndocrine-related cancer2014

Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution.

Mabel Ryder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.